Literature DB >> 23689613

Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains.

Yobana Perez-Cervera1, Vanessa Dehennaut, Moyira Aquino Gil, Katia Guedri, Carlos Josué Solórzano Mata, Stéphanie Olivier-Van Stichelen, Jean-Claude Michalski, François Foulquier, Tony Lefebvre.   

Abstract

Lipid microdomains (rafts) are cholesterol-enriched dynamic ordered lipid domains belonging to cell membranes involved in diverse cellular functions, including signal transduction, membrane trafficking, and infection. Many studies have reported relationships between insulin signaling and lipid rafts. Likewise, links between insulin signaling and O-GlcNAcylation have also been described. However, the potential connection between O-GlcNAc and raft dynamics remains unexplored. Here we show that O-GlcNAc and the enzyme that creates this modification, O-GlcNAc transferase (OGT), are localized in rafts. On insulin stimulation, we observe time-dependent increases in OGT expression and localization within rafts. We show that these processes depend on activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Inhibition of OGT does not significantly affect cholesterol synthesis and raft building but decreases insulin receptor expression and PI3K and mitogen-activated protein kinase pathway activation. Taken together, these findings indicate that O-GlcNAcylation, lipid rafts, and signaling pathways are spatiotemporally coordinated to enable fundamental cellular functions.

Entities:  

Keywords:  OGT; PI3K pathway; lipid rafts

Mesh:

Substances:

Year:  2013        PMID: 23689613     DOI: 10.1096/fj.12-217984

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

1.  E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.

Authors:  Sujith Dassanayaka; Kenneth R Brittian; Andrea Jurkovic; Lauren A Higgins; Timothy N Audam; Bethany W Long; Linda T Harrison; Giuseppe Militello; Daniel W Riggs; Mitali G Chitre; Shizuka Uchida; Senthilkumar Muthusamy; Anna M Gumpert; Steven P Jones
Journal:  Basic Res Cardiol       Date:  2019-05-31       Impact factor: 17.165

2.  Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification.

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

Review 3.  Protein O-GlcNAcylation: emerging mechanisms and functions.

Authors:  Xiaoyong Yang; Kevin Qian
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

4.  Cross regulation between mTOR signaling and O-GlcNAcylation.

Authors:  Ninon Very; Agata Steenackers; Caroline Dubuquoy; Jeanne Vermuse; Laurent Dubuquoy; Tony Lefebvre; Ikram El Yazidi-Belkoura
Journal:  J Bioenerg Biomembr       Date:  2018-03-09       Impact factor: 2.945

Review 5.  Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.

Authors:  Ilhan Akan; Stephanie Olivier-Van Stichelen; Michelle R Bond; John A Hanover
Journal:  J Neurochem       Date:  2017-11-20       Impact factor: 5.372

6.  Spatiotemporal Proximity Labeling Tools to Track GlcNAc Sugar-Modified Functional Protein Hubs during Cellular Signaling.

Authors:  Yimin Liu; Zachary M Nelson; Ali Reda; Charlie Fehl
Journal:  ACS Chem Biol       Date:  2022-07-12       Impact factor: 4.634

Review 7.  Regulation of cancer metabolism by O-GlcNAcylation.

Authors:  Zhonghua Li; Wen Yi
Journal:  Glycoconj J       Date:  2013-12-10       Impact factor: 2.916

8.  Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.

Authors:  Sadia Raab; Alexis Gadault; Ninon Very; Amélie Decourcelle; Steffi Baldini; Céline Schulz; Marlène Mortuaire; Quentin Lemaire; Stéphan Hardivillé; Vanessa Dehennaut; Ikram El Yazidi-Belkoura; Anne-Sophie Vercoutter-Edouart; Ganna Panasyuk; Tony Lefebvre
Journal:  Cell Mol Life Sci       Date:  2021-05-27       Impact factor: 9.261

9.  E2F1 Transcription Factor Regulates O-linked N-acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Expression.

Authors:  Senthilkumar Muthusamy; Kyung U Hong; Sujith Dassanayaka; Tariq Hamid; Steven P Jones
Journal:  J Biol Chem       Date:  2015-11-02       Impact factor: 5.157

Review 10.  O-GlcNAcylation in Hyperglycemic Pregnancies: Impact on Placental Function.

Authors:  Jie Ning; Huixia Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.